Advertisement
Advertisement
PLX
Protalix BioTherapeutics, Inc. Common Stock
2.12
USDSponsored
-0.03
-1.40%
May 01, 15:59 UTC -4
Closed
After-Market
2.12
0.00
0.00%
Protalix BioTherapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 170.81M |
| Beta | -0.09 |
| Earnings Per Share (EPS) | -0.09 |
| Price-to-Book (P/B) Ratio | 3.80 |
| Operating Margin | -12.52% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -13.46% |
| Current Ratio | 2.51% |
| Free Cash Flow | -13.63M |
Trending Stocks
Advertisement